New pattern of whole-process management of ovarian cancer

Zhou Qi

doi:10.13406/j.cnki.cyxb.002804

您当前的位置：

首页 >

文章列表页 >

New pattern of whole-process management of ovarian cancer

更新时间：2024-01-09

- New pattern of whole-process management of ovarian cancer
- Journal of Chongqing Medical University Vol. 46, Issue 6, Pages: 635-639(2021)
- 作者机构：
  
  重庆大学附属肿瘤医院妇科肿瘤中心,重庆,400030
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.002804
  CLC： R711.73
- Published：2021，
扫描看全文
Zhou Qi. New pattern of whole-process management of ovarian cancer. [J]. Journal of Chongqing Medical University 46(6):635-639(2021)
DOI：

Zhou Qi. New pattern of whole-process management of ovarian cancer. [J]. Journal of Chongqing Medical University 46(6):635-639(2021) DOI： 10.13406/j.cnki.cyxb.002804.

摘要

卵巢癌是常见且致死率最高的妇科肿瘤，反复复发，疗效差，是亟待解决的临床难题。卵巢癌全程管理有望提高患者生存期，提高患者生活质量。本文在回顾卵巢癌治疗措施的发展、演进，在卵巢癌手术、化疗、靶向和免疫治疗进展的基础上，引发了对复发性卵巢癌的诊断和思考，并进一步提出了卵巢癌全生命周期的规范化管理。

Abstract

Ovarian cancer is a common gynecological tumor with the highest mortality rate

which has repeated recurrence and poor efficacy. It is an urgent clinical problem to be solved. Ovarian cancer is expected to improve the survival time and quality of life of patients with whole-course management based on the progress of targeted and immunotherapy

the diagnosis and thinking of recurrent ovarian cancer are initiated

and the standardized management of ovarian cancer throughout its life cycle is further proposed.

关键词

卵巢癌全生命周期管理

Keywords

ovarian cancerthe whole life cyclemanagement

references

Views

225

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Interpretation of China’s first “Expert Consensus on Diagnosis and Treatment for Elderly with Thyroid Diseases in China”

RNAi technology applied to the preparation of molecular probes for diagnosis and treatment of ovarian cancer

Effect of silencing mdrl gene by RNA interference with adriamycin on proliferation of SKOV₃/ADM

Effects of curcumin on proliferation in human ovary cancer cell line SKOV₃

Survivin expression in ovarian cancer and its associationwith tumor cellular apoptosis

Related Author

Li Yushu

Shan Zhongyan

Wu Xiaofeng

Wen Ming

WANG Pingling

et al

邓凯贤

张君

Related Institution

Department of Endocrinology，The First Hospital of China Medical University，Institute of Endocrinology of China Medical University，Key Laboratory of Thyroid Diseases ofNational Health Commission of the People’s Republic of China

Department of Radiology,The First Affiliated Hospital of Chongqing Medical University

重庆医科大学病毒性肝炎研究所

Department of Obstetrics and Gynecology,the Second College of Clinical Medicine,Chongqing Medical University

⁰